6

A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and
Page 2: A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and
Page 3: A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and
Page 4: A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and
Page 5: A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and
Page 6: A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and